doi:10.3969/j.issn.1673-8640.2015.10.016

Abstract

CLC Number:

R446.1

Figures/Tables 5

References 11

[1]	VARKI A.Sialic acids in human health and disease[J]. Trends Mol Med,2008,14(8):351-360.
[2]	张嘉宁,汪淑晶. 唾液酸生物学与人类健康和疾病[J]. 生命科学,2011,23(7):678-684.
[3]	刘沛,王舒,李变荣. 血清唾液酸在恶性肿瘤诊断中的临床应用[J]. 检验医学与临床,2012,9(6):687-688.
[4]	National Committee for Clinical Laboratory Standards.Preliminary evaluation of quantitative clinical laboratory methods[S].EP10-A2,NCCLS,2002.
[5]	程明刚,程静,刘香萍,等.应用NCCLS EP10-A2文件初步评价定量钙测定的性能[J].热带医学杂志,2010,10(11):1289-1292.
[6]	刘怀平,刘树业.实验室认可中封闭检测系统的性能验证及评价[J].现代预防医学,2011,38(19):3981-3984.
[7]	张葵. 定量检测系统方法学性能验证实验的基本方法[J].临床检验杂志,2009,27(5):321-323.
[8]	National Committee for Clinical Laboratory Standards. Evaluation of precision performance of clinical chemistry devices; approved guideline[S]. EP5-A2,NCCLS,1999.
[9]	National Committee for Clinical Laboratory Standards. Evaluation of the linearity of quantitative analytical methods: a statistical approach; approved guideline[S]. EP6-A,NCCLS,2003.
[10]	National Committee for Clinical Laboratory Standards. Method comparison and bias estimation using patient samples: approved guideline[S]. EP9-A2,NCCLS,2002.
[11]	National Committee for Clinical Laboratory Standards. Interference testing in clinical chemistry: approved guideline[S]. EP7-A2,NCCLS,2002.

时间	低值	中值	高值
第1天	55.1±0.6	107.8±0.3	160.5±1.2
第2天	54.8±0.3	108.1±0.5	160.8±1.0
第3天	55.0±0.5	107.7±1.0	160.9±0.6
第4天	55.5±0.3	107.7±0.2	160.8±0.9
第5天	55.1±0.4	107.2±0.3	160.5±0.6
总均值(Y)	55.1	107.7	160.7
靶值(X)	55.0	107.5	160.0
偏差(Y-X)	0.1	0.2	0.7
允许偏差	±2.8	±5.4	±8.0
可接受性评价	可接受	可接受	可接受

时间	低值	中值	高值
第1天	55.1±0.6	107.8±0.3	160.5±1.2
第2天	54.8±0.3	108.1±0.5	160.8±1.0
第3天	55.0±0.5	107.7±1.0	160.9±0.6
第4天	55.5±0.3	107.7±0.2	160.8±0.9
第5天	55.1±0.4	107.2±0.3	160.5±0.6
总均值(Y)	55.1	107.7	160.7
靶值(X)	55.0	107.5	160.0
偏差(Y-X)	0.1	0.2	0.7
允许偏差	±2.8	±5.4	±8.0
可接受性评价	可接受	可接受	可接受

项目	低值	中值	高值
合并批内方差(R)	0.17	0.30	0.73
日间均值方差(S)	0.07	0.10	0.03
校正的日间方(T)	0.01	0.00	0.00
总方差(U)	0.18	0.30	0.73
总标准偏差(V)	0.42	0.55	0.86
总均值(Y)	55.10	107.70	160.70
总不精密度[CV%(W)]	0.76	0.51	0.53
允许不精密度[CV(%)]	5	5	5
可接受性评价	可接受	可接受	可接受

项目	低值	中值	高值
合并批内方差(R)	0.17	0.30	0.73
日间均值方差(S)	0.07	0.10	0.03
校正的日间方(T)	0.01	0.00	0.00
总方差(U)	0.18	0.30	0.73
总标准偏差(V)	0.42	0.55	0.86
总均值(Y)	55.10	107.70	160.70
总不精密度[CV%(W)]	0.76	0.51	0.53
允许不精密度[CV(%)]	5	5	5
可接受性评价	可接受	可接受	可接受

批次	项目	截距	斜率	携带污染 (%)	非线性	漂移
1	数值	-0.085	1.004	0.546	0.000	0.058
	t值	-0.304	0.429	0.653	0.083	0.516
2	数值	-0.491	1.008	-0.312	0.000	0.096
	t值	-2.217	1.252	-0.469	-0.267	1.092
3	数值	-0.600	1.009	-0.388	0.000	-0.055
	t值	-2.136	1.083	-0.460	0.197	-0.494
4	数值	0.158	1.003	-0.412	0.000	-0.066
	t值	0.828	0.611	-0.717	0.640	-0.870
5	数值	-0.347	1.004	0.403	0.000	-0.059
	t值	-2.612	1.099	1.011	1.332	-1.106
总均值	数值	-0.273	1.006	-0.032	0.000	-0.005
	t值	-1.288	0.895	0.003	0.397	-0.172

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 5

References 11

Related Articles 15

Recommended Articles

Metrics

[1]	GAO Zikang, CHEN Jing. Construction of a nomogram prediction model for the prognosis of patients with depressive disorder based on the characteristics of peripheral blood lymphocyte subsets [J]. Laboratory Medicine, 2025, 40(12): 1146-1152.
[2]	WANG Tian, ZHANG Yun, BAI Yi, ZHAI Weibin, ZHAO Hai. Roles of PIV，SII and NPAR in the diagnosis of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites [J]. Laboratory Medicine, 2025, 40(12): 1153-1158.
[3]	HUANG Ting, XU Yan, SHI Qingxing, PENG Ying. Roles of miR-944 and MARCH7 mRNA in prognosis assessment of non-small cell lung cancer patients [J]. Laboratory Medicine, 2025, 40(12): 1159-1164.
[4]	LI Minghong, MIN Cuili, GUO Qingbo, MA Lujuan. Predictive roles of serum 25（OH）D and SAA for the response to immunosuppressive therapy in autoimmune hepatitis [J]. Laboratory Medicine, 2025, 40(12): 1165-1170.
[5]	ZHEN Di, JIA Bin, MENG Xianyi. Roles of serum sPD-1 and sTWEAK levels in patients with ulcerative colitis in disease monitoring and prognosis assessment [J]. Laboratory Medicine, 2025, 40(12): 1171-1176.
[6]	ZHAO Yilin, XU Yan, YIN Hui. Roles of serum miR-145-5p，miR-200C-3p and miR-1290 in prognosis assessment of patients with papillary thyroid carcinoma [J]. Laboratory Medicine, 2025, 40(12): 1177-1182.
[7]	LI Song, XIANG Xu. Risk factors for poor prognosis in elderly patients with severe fever and thrombocytopenia syndrome and their clinical significance [J]. Laboratory Medicine, 2025, 40(12): 1183-1189.
[8]	CHANG Nan, WEI Yali, LU Qifeng, LI Tian, HOU Tingting, LI Yuan, ZHU Mengyu, SHEN Yajuan. A machine learning early warning model for acute promyelocytic leukemia based on blood cell analyzer parameters [J]. Laboratory Medicine, 2025, 40(12): 1190-1196.
[9]	. [J]. Laboratory Medicine, 2025, 40(12): 1197-1202.
[10]	. [J]. Laboratory Medicine, 2025, 40(12): 1216-1221.
[11]	. [J]. Laboratory Medicine, 2025, 40(12): 1222-1226.
[12]	BAO Wen. Application and prospect of microsatellite instability determination in tumor diagnosis and treatment [J]. Laboratory Medicine, 2025, 40(12): 1227-1231.
[13]	XIONG Ying, GUO Wei. From generic to personalized：the evolution and frontiers of indirect methods for establishing reference interval [J]. Laboratory Medicine, 2025, 40(11): 1035-1041.
[14]	CHEN Yanqin, FAN Lina, YANG Dagan. Six indirect method algorithms for establishing the reference range of serum cystatin C for adults in Hangzhou and consistency analysis [J]. Laboratory Medicine, 2025, 40(11): 1047-1052.
[15]	LIU Chunyan, NIU Shumin, DENG Zhaohui, LIANG Mengjie, ZHANG Xin. Establishing the reference ranges for AFP，CEA，CA72-4 and CA19-9 in Urumqi region by indirect method [J]. Laboratory Medicine, 2025, 40(11): 1053-1058.